You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 216356

✉ Email this page to a colleague

« Back to Dashboard

NDA 216356 describes TRIENTINE HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Amneal, Chartwell Rx, Dr Reddys, Eci Pharms Llc, Hetero Labs Ltd Iii, Lupin Ltd, MSN, Navinta Llc, Ph Health, Rising, Watson Labs Teva, and Zydus Pharms, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the TRIENTINE HYDROCHLORIDE profile page.

The generic ingredient in TRIENTINE HYDROCHLORIDE is trientine hydrochloride. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.

Summary for 216356

Tradename:	TRIENTINE HYDROCHLORIDE
Applicant:	Hetero Labs Ltd Iii
Ingredient:	trientine hydrochloride
Patents:	0

Pharmacology for NDA: 216356

Mechanism of Action	Metal Chelating Activity

Medical Subject Heading (MeSH) Categories for 216356

Chelating Agents

Suppliers and Packaging for NDA: 216356

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TRIENTINE HYDROCHLORIDE	trientine hydrochloride	CAPSULE;ORAL	216356	ANDA	Camber Pharmaceuticals, Inc.	31722-683	31722-683-01	1 BOTTLE in 1 CARTON (31722-683-01) / 100 CAPSULE in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	250MG
Approval Date:	Jun 23, 2022	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.